INTEGRA LIFESCIENCES HOLDINGS CORP Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $761.00K, a 20.48% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, employee stock purchase plan for the quarter ending 2025-03-31 was $957.00K, a 0.83% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, employee stock purchase plan for the quarter ending 2024-03-31 was $965.00K, a 12.83% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, employee stock purchase plan for the quarter ending 2023-03-31 was $1.11M, a 2.69% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, employee stock purchase plan for fiscal 2025 was $957.00K, a 0.83% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, employee stock purchase plan for fiscal 2024 was $965.00K, a 12.83% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.11M, a 2.69% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, employee stock purchase plan for fiscal 2022 was $1.08M, a 4.35% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-03-31 | $761.00K 10-Q · filed 2026-07-29 | |
| 2025-12-31 | $957.00K 10-K · filed 2026-02-26 | |
| 2025-03-31 | $957.00K 10-Q · filed 2026-07-29 | |
| 2024-12-31 | $965.00K 10-K · filed 2026-02-26 | |
| 2024-03-31 | $965.00K 10-Q · filed 2025-10-30 | |
| 2023-12-31 | $1.11M 10-K · filed 2026-02-26 | |
| 2023-03-31 | $1.11M 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $1.08M 10-K · filed 2025-02-25 | |
| 2022-03-31 | $1.08M 10-Q · filed 2023-10-25 | |
| 2021-12-31 | $1.13M 10-K · filed 2024-02-28 | |
| 2021-03-31 | $1.13M 10-Q · filed 2022-10-26 | |
| 2020-12-31 | $694.00K 10-K · filed 2023-02-22 | |
| 2020-03-31 | $694.00K 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $716.00K 10-K · filed 2022-02-24 | |
| 2019-03-31 | $716.00K 10-Q · filed 2020-10-29 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $553.00K 10-K · filed 2021-02-23 |
| 2018-03-31 | $553.00K 10-Q · filed 2019-07-25 | |
| 2017-12-31 | $509.00K 10-K · filed 2020-02-21 | |
| 2017-03-31 | $509.00K 10-Q · filed 2018-11-01 | |
| 2016-12-31 | $391.00K 10-K · filed 2019-02-26 | |
| 2015-12-31 | $231.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $286.00K 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |